CBP-1018
Product Specifications
UNSPSC Description
CBP-1018 is a PDC (peptide-drug conjugate) formed by dual ligands targeting FRα/TRPV6 conjugated with Monomethyl auristatin E (HY-15162) through a linker (HY-78738). CBP-1018 holds potential for research in the field of breast cancer[1].
Target Antigen
Peptide-Drug Conjugate (PDC); TRP Channel
Type
Peptides
Related Pathways
Membrane Transporter/Ion Channel;Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cbp-1018.html
Smiles
O[C@@H](C1=CC=CC=C1)[C@@H](C)NC([C@H](C)[C@H]([C@@]2([H])N(CCC2)C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@H](C(C)C)N(C)C(OCC3=CC=C(C=C3)NC([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC(CCCCCN4C(C(CC4=O)SC[C@@H](C(N[C@H](C(N)=O)CCCCNC(CC[C@@H](C(O)=O)NC(C5=CC=C(C=C5)NCC(N=C67)=CNC6=NC(N)=NC7=O)=O)=O)=O)NC([C@H](CCCCN)NC([C@H](CC(O)=O)NC([C@H](CC(O)=O)NC(CC8=CC=C(C=C8)CNC(NCCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)OC)=O
Molecular Weight
2839.18
References & Citations
[1]Li X, et al. LC-MS/MS method for dual-ligand peptide-drug CBP-1018 and its deconjugated payload MMAE including sample stabilization strategy for its MC-Val-Cit-PABC linker. Talanta. 2024 Nov 1;279:126596.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P10740/CBP-1018-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P10740/
Clinical Information
No Development Reported
CAS Number
2923068-30-6
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6505613-01 0.1 mL
VEGFR-2, Phosphorylated (Tyr996) (Vascular Endothelial Growth Factor Receptor 2, VEGFR-2, Kinase Insert Domain Receptor, Protein-tyrosine Kinase Receptor Flk-1, Fetal Liver Kinase 1, FLK-1, CD309 antigen, KDR, FLK1) (MaxLight 490)
Ask
View Details 
MBS6505613-02 5x 0.1 mL
VEGFR-2, Phosphorylated (Tyr996) (Vascular Endothelial Growth Factor Receptor 2, VEGFR-2, Kinase Insert Domain Receptor, Protein-tyrosine Kinase Receptor Flk-1, Fetal Liver Kinase 1, FLK-1, CD309 antigen, KDR, FLK1) (MaxLight 490)
Ask
View Details 